IL6 and neoplasm: After tumour cells migrate to the endosteum, tumour cells stimulate the RANKL expression in osteoblasts through the production of PTHrP, prostaglandin E2, interleukin (IL)-6, IL-1β, enhancing osteoclastic bone resorption [48].